当前位置： SCI文献检索 > BRITISH JOURNAL OF CLINICAL PHARMACOLOGY期刊下所有文献 > TPMT*26 (208F-->L), a novel mutation detected in a Chinese.

TPMT*26 (208F-->L), a novel mutation detected in a Chinese.

Abstract：

AIMS:Azathioprine, mercaptopurine and thioguanine are commonly used to treat autoimmune disorders, leukaemia and solid organ transplantation. However, azathiopurine and its metabolites can also cause adverse reactions such as myelosuppression. These manifestations may be attributed to polymorphisms or mutations in the thiopurine methyltransferase (TPMT) gene that might result in low TPMT enzyme activity. Our aim was to investigate if azathioprine-related myelosuppression is associated with TPMT polymorphism, which in turn affects its enzyme activity. METHODS:A 61-year-old Chinese man with severe atopic eczema developed moderate myelosuppression with standard doses of azathioprine. His TPMT activity was measured using radiochemical assay. Genotyping of TPMT *3C, *3A and *6 were screened using polymerase chain reaction-restriction fragment length polymorphism. Novel mutation was detected by sequencing. Family studies of his three other siblings were performed. RESULTS:After 4 weeks of azathioprine treatment, the patient's white blood cells and absolute neutrophil count dropped by 40-45%. He was then taken off azathioprine, and blood counts returned to normal. TPMT activity test showed intermediate levels of 9.1 nmol h(-1) ml(-1) peripheral red blood cells (pRBC). Resequencing of the TPMT gene revealed a missense mutation Phe-->Leu at 208 aa position in exon 9 (ss105107120). Two of his three siblings were heterozygous for 208F-->L, which accounts for the decreased enzyme activity (brother 8.9 nmol h(-1) ml(-1) pRBC, sister 8.8 nmol h(-1) ml(-1) pRBC). The remaining sibling had wild-type allele with normal enzyme activity. Screening of 100 normal healthy Chinese subjects did not reveal any individual with this mutation. CONCLUSION:We report a novel mutation TPMT*26 (208F-->L) associated with a decrease in TPMT enzyme activity.

journal_name

Br J Clin Pharmacol

journal_title

British journal of clinical pharmacology

authors

Kham SK,Soh CK,Aw DC,Yeoh AE

doi

10.1111/j.1365-2125.2009.03405.x

subject

Has Abstract

pub_date

2009-07-01 00:00:00

pages

120-3

issue

1

eissn

0306-5251

issn

1365-2125

pii

BCP3405

journal_volume

68

pub_type

杂志文章

相关文献

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY文献大全
  • Cimetidine, but not oxmetidine, penetrates into the cerebrospinal fluid after a single intravenous dose.

    abstract：:1 Thirty-six patients with various neurological diseases or symptoms received single intravenous doses of either cimetidine 400 mg (n = 19) or oxmetidine 200 mg (n = 17), 15 or 60 min before a diagnostic lumbar puncture. 2 In the 15 min CSF samples concentrations of cimetidine were detectable but not measurable in 5 a...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1111/j.1365-2125.1982.tb02042.x

    authors： Jönsson KA,Eriksson SE,Kagevi I,Norlander B,Bodemar G,Walan A

    更新日期：1982-12-01 00:00:00

  • Population exposure-safety analysis of cediranib for Phase I and II studies in patients with cancer.

    abstract：AIMS:A multistudy analysis of cediranib, a potent, selective inhibitor of all three vascular endothelial growth factor receptors (VEGFR-1, -2 and -3), was conducted to establish population exposure-safety models for the relationship of cediranib exposure to the safety endpoints, diastolic and systolic blood pressure (D...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/bcp.13495

    authors： Al-Huniti N,Petersson K,Tang W,Masson E,Li J

    更新日期：2018-04-01 00:00:00

  • Regulatory Science and Innovation Programme for Europe (ReScIPE): A proposed model.

    abstract：:Regulatory science underpins the objective evaluation of medicinal products. It is therefore imperative that regulatory science and expertise remain at the cutting edge so that innovations of ever-increasing complexity are translated safely and swiftly into effective, high-quality therapies. We undertook a comprehensi...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/bcp.14099

    authors： Hines PA,Guy RH,Brand A,Humphreys AJ,Papaluca-Amati M

    更新日期：2020-12-01 00:00:00

  • Development of AITC-induced dermal blood flow as a translational in vivo biomarker of TRPA1 activity in human and rodent skin.

    abstract：BACKGROUND AND PURPOSE:Develop a translational assay of Transient Receptor Potential Ankyrin 1 (TRPA1) activity for use as a preclinical and clinical biomarker. EXPERIMENTAL APPROACH:Allyl isothiocyanate (AITC), capsaicin or citric acid were applied to ears of wildtype and Trpa1-knock out (Trpa1 KO) rats, and changes ...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/bcp.14370

    authors： Joseph V,Yang X,Gao SS,Elstrott J,Weimer RM,Theess W,Thrasher C,Singh N,Lin J,Bauer RN

    更新日期：2021-01-01 00:00:00

  • Antidepressant drugs, convulsions and epilepsy.

    abstract：:1 Evidence concerning the convulsant effects of non-monoamine oxidase inhibitor antidepressant drugs has been reviewed. 2 Mianserin is convulsant in therapeutic doses but seizures have not been reported following overdose. 3 The convulsant effects of mianserin are probably no greater than for other non-monoamine oxida...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.1983.tb05878.x

    authors： Richens A,Nawishy S,Trimble M

    更新日期：1983-01-01 00:00:00

  • In vitro and physiologically-based pharmacokinetic based assessment of drug-drug interaction potential of canagliflozin.

    abstract：AIMS:Canagliflozin is a recently approved drug for use in the treatment of type 2 diabetes. The potential for canagliflozin to cause clinical drug-drug interactions (DDIs) was assessed. METHODS:DDI potential of canagliflozin was investigated using in vitro test systems containing drug metabolizing enzymes or transport...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/bcp.13186

    authors： Mamidi RNVS,Dallas S,Sensenhauser C,Lim HK,Scheers E,Verboven P,Cuyckens F,Leclercq L,Evans DC,Kelley MF,Johnson MD,Snoeys J

    更新日期：2017-05-01 00:00:00

  • Mexiletine disposition: individual variation in response to urine acidification and alkalinisation.

    abstract：:The disposition of mexiletine has been studied in five subjects on two occasions with urine pH controlled at 5.0 and at 8.0. With acid urine total plasma clearance was similar in all subjects (462 to 497 ml min-1) and the plasma half-life ranged from 3.8 to 9.2 h (mean 6.7 h). With alkaline urine the total plasma clea...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.1983.tb02162.x

    authors： Mitchell BG,Clements JA,Pottage A,Prescott LF

    更新日期：1983-09-01 00:00:00

  • Acute management of severe hypertension with oral labetalol.

    abstract：:1 Six previously untreated emergency admissions to hospital with severe hypertension were given oral treatment with labetalol. 2 Pre-treatment diastolic BP exceeded 130 mmHg, and clinical evidence of either accelerated hypertension or encephalopathy was present. 3 Hypotensive response after treatment followed two patt...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：

    authors： Ghose RR

    更新日期：1979-01-01 00:00:00

  • The effect of bosentan on the pharmacokinetics of digoxin in healthy male subjects.

    abstract：AIMS:To investigate the effect of multiple oral dose treatment with the endothelin receptor antagonist bosentan on the pharmacokinetics of digoxin in healthy subjects. METHODS:This was an open-label, randomized, two-way crossover study in 18 evaluable young male subjects. They received, on two occasions which were sep...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1046/j.1365-2125.1999.00946.x

    authors： Weber C,Banken L,Birnboeck H,Nave S,Schulz R

    更新日期：1999-06-01 00:00:00

  • High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients.

    abstract：AIMS:To investigate the relationships between pretreatment folate concentrations, MTX pharmacokinetics and acute toxicities following high dose methotrexate (HD MTX) therapy. METHODS:MTX and its major extracellular metabolite 7-OH-MTX were measured in eight serum samples per HD MTX cycle in 65 consecutive osteosarcoma...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.2011.04054.x

    authors： Holmboe L,Andersen AM,Mørkrid L,Slørdal L,Hall KS

    更新日期：2012-01-01 00:00:00

  • Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

    abstract：:Highly active antiretroviral therapy is recommended for HIV-infected pregnant women to prevent mother-to-child transmission. The specific physiological background induced by pregnancy leads to significant changes in maternal pharmacokinetics, suggesting potential variability in plasma concentrations of antiretrovirals...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章,评审

    doi：10.1111/j.1365-2125.2008.03220.x

    authors： Roustit M,Jlaiel M,Leclercq P,Stanke-Labesque F

    更新日期：2008-08-01 00:00:00

  • Population pharmacokinetic/pharmacodynamic analysis of CCR5 receptor occupancy by maraviroc in healthy subjects and HIV-positive patients.

    abstract：BACKGROUND:Maraviroc, a noncompetitive antagonist of the CCR5 coreceptor, was recently approved in the USA as a treatment of HIV infection. For antiretroviral agents that target the virus, antiviral effect can be related to some extent to plasma drug concentrations. For CCR5 antagonists that target the host cells, rece...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章,meta分析

    doi：10.1111/j.1365-2125.2008.03140.x

    authors： Rosario MC,Jacqmin P,Dorr P,James I,Jenkins TM,Abel S,van der Ryst E

    更新日期：2008-04-01 00:00:00

  • Commentary on the EMA Reflection Paper on the use of extrapolation in the development of medicines for paediatrics.

    abstract：:Adopted guidelines reflect a harmonised European approach to a specific scientific issue and should reflect the most recent scientific knowledge. However, whilst EU regulations are mandatory for all member states and EU directives must be followed by national laws in line with the directive, EMA guidelines do not have...

    journal_title：British journal of clinical pharmacology

    pub_type：

    doi：10.1111/bcp.13883

    authors： Ollivier C,Thomson A,Manolis E,Blake K,Karlsson KE,Knibbe CAJ,Pons G,Hemmings R

    更新日期：2019-04-01 00:00:00

  • Effects of Schisandra sphenanthera extract on the pharmacokinetics of tacrolimus in healthy volunteers.

    abstract：AIM:To assess the effect of Schisandra sphenanthera extract (SchE) on the pharmacokinetics of tacrolimus in healthy volunteers. METHODS:Twelve healthy male volunteers were orally treated with SchE, three capsules twice daily for 13 days. Pharmacokinetic investigations of oral tacrolimus administration at 2 mg were per...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.2007.02922.x

    authors： Xin HW,Wu XC,Li Q,Yu AR,Zhu M,Shen Y,Su D,Xiong L

    更新日期：2007-10-01 00:00:00

  • Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.

    abstract：:1. Studies using human liver microsomes and six recombinant human CYP isoforms (i.e. CYP1A2, 2A6, 2B6, 2D6, 2E1 and 3A4) were performed to identify the cytochrome P450 (CYP) isoform(s) involved in the ring 4-hydroxylation and side-chain N-desisopropylation of propranolol enantiomers in humans. 2. alpha-Naphthoflavone ...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.1995.tb04472.x

    authors： Yoshimoto K,Echizen H,Chiba K,Tani M,Ishizaki T

    更新日期：1995-04-01 00:00:00

  • Bayes-based dosing of infliximab in inflammatory bowel diseases: Short-term efficacy.

    abstract：AIMS:Therapeutic drug monitoring of infliximab can guide clinical decisions in patients with loss of response and in those who can benefit from a de-intensification. The aim of this study was to determine the impact of therapeutic drug monitoring combined with Bayesian forecasting methodology on clinical response in a ...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/bcp.14410

    authors： Santacana Juncosa E,Rodríguez-Alonso L,Padullés Zamora A,Guardiola J,Rodríguez-Moranta F,Serra Nilsson K,Bas Minguet J,Morandeira Rego F,Colom Codina H,Padullés Zamora N

    更新日期：2020-06-03 00:00:00

  • Comparison of gentamicin dose estimates derived from manual calculations, the Australian 'Therapeutic Guidelines: Antibiotic' nomogram and the SeBA-GEN and DoseCalc software programs.

    abstract：AIM:To compare gentamicin dose estimates from four predictive methods. METHODS:A retrospective study was conducted, comprising patients at Fremantle Hospital who received gentamicin therapy and had at least one gentamicin serum concentration reported. A manual calculation method, the Australian 'Therapeutic Guidelines...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.2004.02201.x

    authors： Mohan M,Batty KT,Cooper JA,Wojnar-Horton RE,Ilett KF

    更新日期：2004-11-01 00:00:00

  • Drug expenditure in hospitals: what do German ward physicians know?

    abstract：AIMS:Ward physicians hold key positions in the course of efforts to reduce drug expenditures in hospitals. This study evaluated the knowledge of German hospital physicians with respect to the daily therapeutic costs of 21 frequently used drugs. METHODS:A questionnaire survey was carried out among 168 ward physicians f...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1046/j.1365-2125.2001.01336.x

    authors： Schnurrer JU,Stichtenoth DO,Troost R,Frölich JC

    更新日期：2001-04-01 00:00:00

  • 5-hydroxytryptamine and depression: a model for the interaction of normal variance with pathology.

    abstract：:1 Theories linking 5-hydroxytryptamine (5-HT) with depression are briefly reviewed. The various experimental strategies adopted to investigate this relationship, examination of autopsy data, CSF metabolite data, 5-HT re-uptake patterns in human blood platelets and imipramine binding studies in human platelets, are dis...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.1983.tb02130.x

    authors： Goodwin FK,Post RM

    更新日期：1983-01-01 00:00:00

  • Pharmacokinetics of cysteamine bitartrate following gastrointestinal infusion.

    abstract：AIMS:Although cysteamine was first used in the treatment of cystinosis in 1976 and approved by the FDA as cysteamine bitartrate (Cystagon) in 1994, surprisingly little pharmacological data are available for this compound. Cysteamine and its related drugs are currently being evaluated for the treatment of Huntington's a...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.2006.02734.x

    authors： Fidler MC,Barshop BA,Gangoiti JA,Deutsch R,Martin M,Schneider JA,Dohil R

    更新日期：2007-01-01 00:00:00

  • No relevant pharmacokinetic interaction between pantoprazole and mycophenolate in renal transplant patients: a randomized crossover study.

    abstract：AIMS:Mycophenolic acid (MPA) suppresses lymphocyte proliferation through inosine monophosphate dehydrogenase (IMPDH) inhibition. Two formulations have been approved: mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS). Pantoprazole (PAN) inhibits gastric acid secretion, which may alter MPA expo...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章,随机对照试验

    doi：10.1111/bcp.12664

    authors： Rissling O,Glander P,Hambach P,Mai M,Brakemeier S,Klonower D,Halleck F,Singer E,Schrezenmeier EV,Dürr M,Neumayer HH,Budde K

    更新日期：2015-11-01 00:00:00

  • Drug disposition before and after gastric bypass: fenofibrate and posaconazole.

    abstract：AIMS:Roux-en-Y gastric bypass (RYGB) alters the anatomical structure of the gastrointestinal tract, which can result in alterations in drug disposition. The aim of the present study was to evaluate the oral disposition of two compounds belonging to the Biopharmaceutical Classification System Class II - fenofibrate (bil...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章

    doi：10.1111/bcp.13054

    authors： Gesquiere I,Hens B,Van der Schueren B,Mols R,de Hoon J,Lannoo M,Matthys C,Foulon V,Augustijns P

    更新日期：2016-11-01 00:00:00

  • Biopsy assessment of drug efficacy in the gastrointestinal tract.

    abstract：:When using biopsy pathology in clinical pharmacology to assess drug efficacy in the gastrointestinal tract, a number of questions must be answered: Is the biopsy necessary or more effective than macroscopic views by endoscopy? Can we extract maximal information from the specimen? Are there surrogate serum or other mar...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章,评审

    doi：10.1046/j.1365-2125.2003.01981.x

    authors： Walker MM

    更新日期：2003-11-01 00:00:00

  • Sedation for gastroscopy: a comparative study of midazolam and Diazemuls in patients with and without cirrhosis.

    abstract：:A double-blind controlled study comparing the effects of intravenous Diazemuls (0.15 mg kg-1) with midazolam (0.07 mg kg-1) in patients with normal liver function and with cirrhosis and portal hypertension is described. The clinical effect of the two drugs was assessed by serial tests of psychomotor function before an...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1111/j.1365-2125.1986.tb02952.x

    authors： Hamdy NA,Kennedy HJ,Nicholl J,Triger DR

    更新日期：1986-12-01 00:00:00

  • Experience with labetalol in hypertension.

    abstract：:1 The effect of labetalol has been assessed in an open clinical trial in 19 patients with sub-optimal control of blood pressure on other therapy, and in a placebo-controlled cross-over study. Most patients were taking a diuretic before the trial and they continued to do so during the trial. 2 In the open trial, labeta...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Bolli P,Waal-Manning J,Wood AJ,Simpson FO

    更新日期：1976-08-01 00:00:00

  • Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants.

    abstract：AIMS:To characterize milk/plasma (M/P) ratio and infant dose, for venlafaxine (V) and its O-desmethyl metabolite (ODV), in breastfeeding women taking venlafaxine for the treatment of depression, and to determine the plasma concentration and effects of these drugs in their infants. METHODS:Six women (mean age 34.5 year...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1046/j.0306-5251.2001.01518.x

    authors： Ilett KF,Kristensen JH,Hackett LP,Paech M,Kohan R,Rampono J

    更新日期：2002-01-01 00:00:00

  • Multifactorial pharmacogenetic analysis in colorectal cancer patients receiving 5-fluorouracil-based therapy together with cetuximab-irinotecan.

    abstract：AIM:To examine the predictive value of gene polymorphisms potentially linked to toxicity, clinical response, time to progression and overall survival, following cetuximab-tegafur-uracil (UFT)-irinotecan therapy. METHODS:Fifty-two patients with advanced colorectal cancer were enrolled in an ancillary pharmacogenetic st...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.2011.04141.x

    authors： Etienne-Grimaldi MC,Bennouna J,Formento JL,Douillard JY,Francoual M,Hennebelle I,Chatelut E,Francois E,Faroux R,El Hannani C,Jacob JH,Milano G

    更新日期：2012-05-01 00:00:00

  • Gastrointestinal side effects after intravenous erythromycin lactobionate.

    abstract：:Ten healthy normal volunteers received an intravenous infusion of erythromycin lactobionate over 60 min to a total dose of 800 mg (n = 9), and 524 mg (n = 1). Blood samples were collected at 10 min intervals for 100 min and gastric contents aspirated, via a nasogastric tube, from pre-dose to 105 min after start of inf...

    journal_title：British journal of clinical pharmacology

    pub_type： 杂志文章

    doi：10.1111/j.1365-2125.1986.tb05193.x

    authors： Downey KM,Chaput de Saintonge DM

    更新日期：1986-03-01 00:00:00

  • A comparison of the effects of propranolol and oxprenolol on forearm blood flow and skin temperature.

    abstract：:1 The effects of oxprenolol 80 mg and propranolol 80 mg on resting forearm blood flow (RFBF) and skin temperature were compared in seven normotensive subjects, for 4 h after an oral dose. 2 There was a significant fall of RFBF after propranolol (mean +/- s.e. mean 0.74 +/- 0.24 ml 100 g-1 min-1) compared to a smaller ...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1111/j.1365-2125.1981.tb01154.x

    authors： Vandenburg MJ,Conlon C,Ledingham JM

    更新日期：1981-05-01 00:00:00

  • Laboratory investigation of effect of acute doses of nomifensine on a simulated aspect of night-time car driving performance.

    abstract：:1. Six healthy volunteers received single doses of either nomifensine 100 mg, nomifensine 50 mg or placebo at weekly intervals in a randomized double-blind crossover study. 2. Subjects were subjected to a simulated test of car driving at night. 3. Testing lasted about 1.5 h and consisted of measuring responses to ligh...

    journal_title：British journal of clinical pharmacology

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1111/j.1365-2125.1977.tb05748.x

    authors： Hindmarch I

    更新日期：1977-01-01 00:00:00